9KL5

Cryo-EM strucuture of human OAT1 in complex with probenecid

Summary for 9KL5

• Entry DOI: 10.2210/pdb9kl5/pdb
• EMDB information: 62400
• Descriptor: Solute carrier family 22 member 6, 4-(dipropylsulfamoyl)benzoic acid, CHLORIDE ION (3 entities in total)
• Functional Keywords: membrane transporter, antiporter, gout, drug-drug interaction, drug elimination, membrane protein
• Biological source: Homo sapiens (human)
• Total number of polymer chains: 1
• Total formula weight: 62189.84

Authors

Jeon, H.M.,Eun, J.,Kim, Y. (deposition date: 2024-11-14, release date: 2025-11-05, Last modification date: 2025-11-19)

Primary citation

Jeon, H.M.,Eun, J.,Kim, K.H.,Kim, Y.
Cryo-EM structures of human OAT1 reveal drug binding and inhibition mechanisms.
Structure, 33:1856-1866.e5, 2025

PubMed Abstract: The organic anion transporter 1 (OAT1) plays a key role in excreting waste from organic drug metabolism and contributes significantly to drug-drug interactions and drug disposition. However, the structural basis of specific substrate and inhibitor transport by human OAT1 (hOAT1) has remained elusive. We determined four cryogenic electron microscopy (cryo-EM) structures of hOAT1 in its inward-facing conformation: the apo form, the substrate (olmesartan)-bound form with different anions, and the inhibitor (probenecid)-bound form. Structural and functional analyses revealed that Ser203 has an auxiliary role in chloride coordination, and it is a critical residue modulating olmesartan transport via chloride ion interactions. Structural comparisons indicate that inhibitors not only compete with substrates, but also obstruct substrate exit and entry from the cytoplasmic side, thereby increasing inhibitor retention. The findings can support drug development by providing insights into substrate recognition and the mechanism by which inhibitors arrest the OAT1 transport cycle.

PubMed: 40845848
DOI: 10.1016/j.str.2025.07.019

Experimental method

ELECTRON MICROSCOPY (3.33 Å)